Effect of chest pain center accreditation on the efficiency of treatment and clinical prognosis of patients with acute ST-segment elevation myocardial infarction
Objective To investigate the effects of chest pain center accreditation on the efficiency of treatment and clinical prognosis of patients with acute ST-segment elevation myocardial infarction(STEMI)undergoing emergency primary percutaneous coronary intervention(PCI)treatment.Methods Between October 2021 to August 2023,a total of 192 patients with acute STEMI who undergoing PCI at the Chest Pain Center of Shaoyang Central Hospital were selected.The differences in key treatment time points,clinical prognostic indicators,hospitalization time,and hospitalization cost were compared between patients who were admitted before the chest pain center certification(control group,n＝89,from October 2021 to August 2022)and after the chest pain center certification(observation group,n＝103,from August 2022 to August 2023).Results Compared with the control group,the door-to-balloon time,symptom to first medical contact time,symptom to balloon time,first medical contact to balloon time,first medical contact to dual antiplatelet time,first medical contact to electrocardiogram,troponin reporting time,and catheter room activation time were significantly shorter in the observation group,the hospitalization cost and the incidence of in-hospital heart failure decreased in the observation group,the left ventricular ejection fraction increased in the observation group,and all differences were statistically significant(all P＜0.05).There were no significant differences in hospitalization stay,in-hospital mortality between the two groups(all P＞0.05).Conclusion The chest pain center certification has significantly reduced the vascular patency time for treating STEMI patients undergoing PCI,improved treatment efficiency,reduced patient heart failure incidence and economic burden,and improved patient clinical prognosis.
NETL
NSTL
万方数据
